发明申请
US20100267945A1 AMINE DERIVATIVE HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY
审中-公开
具有NPY Y5受体拮抗活性的氨基衍生物
- 专利标题: AMINE DERIVATIVE HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY
- 专利标题(中): 具有NPY Y5受体拮抗活性的氨基衍生物
-
申请号: US12823568申请日: 2010-06-25
-
公开(公告)号: US20100267945A1公开(公告)日: 2010-10-21
- 发明人: Takayuki Okuno , Naoki Kouyama , Masahiro Sakagami
- 申请人: Takayuki Okuno , Naoki Kouyama , Masahiro Sakagami
- 申请人地址: JP Osaka-shi
- 专利权人: Shionogi & Co., Ltd.
- 当前专利权人: Shionogi & Co., Ltd.
- 当前专利权人地址: JP Osaka-shi
- 优先权: JP2006/124762 20060428; JP2006-219606 20060811; JP2007-045587 20070226
- 主分类号: C07D267/14
- IPC分类号: C07D267/14 ; C07D211/14 ; C07D213/74 ; C07D295/135 ; C07D217/04 ; C07D401/04 ; C07D403/04 ; C07F7/18 ; C07C311/14 ; C07C311/08 ; C07D405/04 ; C07C311/05 ; C07D413/04 ; C07D251/42 ; C07D211/76 ; C07D263/58 ; C07D265/36 ; C07D498/04 ; C07D261/20 ; C07D237/20 ; C07D237/22 ; C07D237/34 ; C07D241/20 ; C07D513/04 ; C07D417/04 ; C07D409/04
摘要:
A compound of the formula (I): a pharmaceutically acceptable salt or solvate thereof, where R1 is optionally substituted lower alkyl, Y is —S(O)2—, R2 is hydrogen or optionally substituted lower alkyl, R7 is hydrogen or optionally substituted lower alkyl, X is a group of the formula: where R5 and R6 are each independently hydrogen, a group of the formula: is optionally substituted cycloalkylene, p is 0, and q is 1 or 2, Z is optionally substituted carbocyclyl or optionally substituted heterocyclyl, and provided that a compound wherein Z is fused heterocyclyl consisting of three rings or optionally substituted pyrimidinyl is excluded.
公开/授权文献
信息查询